Stay updated on Celecoxib Impact on SMN2 in SMA Clinical Trial

Sign up to get notified when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Celecoxib Impact on SMN2 in SMA Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for a celecoxib study in people with spinal muscular atrophy is displayed, including its study details and status as terminated.
    Difference
    45%
    Check dated 2026-11-09T12:54:09.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T12:34:06.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A banner was added announcing NIH’s transition to using “Super Intelligence” in place of “Artificial Intelligence.”
    Difference
    1%
    Check dated 2026-10-26T12:16:11.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-19T12:52:22.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-12T14:45:56.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, blocking access to the study details.
    Difference
    18%
    Check dated 2026-09-21T22:27:59.000Z thumbnail image

Stay in the know with updates to Celecoxib Impact on SMN2 in SMA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Celecoxib Impact on SMN2 in SMA Clinical Trial page.